Chuangmei Pharmaceutical Co., Ltd. (“Chuangmei Pharmaceutical”) (Stock Code: 2289) was successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited on 14 December 2015.

Chuangmei Pharmaceutical is one of the leading pharmaceutical distributors in the southern China region. Its distribution network covers the southern China region and other regions such as Fujian province. Chuangmei Pharmaceutical is the third largest privately-owned pharmaceutical distribution company in the southern China region in terms of revenue generated from pharmaceutical distribution business in 2014. It has a variety of product offerings including western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices and cosmetic products. It was rated as “Leading Brand in Pharmaceutical Distribution Industry in Guangdong province” in 2011, "Triple A Credit Enterprise in China" in 2015 and "Best Service to Suppliers of the Pharmaceutical Industry in China for 2013 to 2014" in 2014.

In this listing, Guotai Junan Capital Limited acted as the Sole Sponsor. We acted as the legal advisers to the Sole Sponsor and the Underwriters with respect to Hong Kong laws.